What trends show in AVNS's 2024 quarterly earnings?

Avanos Medical (AVNS) experienced significant fluctuations in its 2024 quarterly earnings, with a notable decline in the fourth quarter. Here's a summary of the key trends observed in AVNS's 2024 earnings: 1. **Significant Decline in Q4 Earnings**: The net income for the fourth quarter of 2024 was -$397.3 million, which is a substantial decrease from the previous quarter's net income of $4.3 million. This indicates a sharp downturn in performance during this period. 2. **Improvement in Q2 and Q3 Earnings**: Prior to the decline in Q4, there was a noticeable improvement in the net income figures for the second and third quarters. The net income for Q2 was $1.8 million, and for Q3, it was $4.3 million. This suggests that Avanos Medical was performing better in the middle part of the year. 3. **Overall Negative Trend in 2024**: If we consider the overall year, the net income for the first quarter was -$900,000, and the earnings for the second and third quarters were positive but lower than expected. The fourth quarter's massive loss pulls the average down, indicating a negative trend for the year. |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |AVNS|AVNS.N|Avanos Medical|2024 Q1|-80|-900000|169| |AVNS|AVNS.N|Avanos Medical|2024 Q2|102.6431718061674|1800000|169| |AVNS|AVNS.N|Avanos Medical|2024 Q3|216.21621621621622|4300000|169| |AVNS|AVNS.N|Avanos Medical|2024 Q4|-3883.8095238095234|-3.973E8|169| In conclusion, Avanos Medical faced a challenging year in 2024, with a significant decline in earnings in the fourth quarter overshadowing the improvements seen in the second and third quarters. The company's performance was negatively impacted, particularly in the last months of the year.